Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin-Reference-Cited by-同舟云学术

Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin

Published:2015 Issue:6 Volume:39 Page:489
ISSN:2233-6079
Container-title:Diabetes & Metabolism Journal
language:en
Short-container-title:Diabetes Metab J

Author:

Kim Ye An¹²,Yoo Won Sang³,Hong Eun Shil¹⁴,Ku Eu Jeong¹¹,Park Kyeong Seon¹⁵,Lim Soo¹⁵,Cho Young Min¹,Park Kyong Soo¹,Jang Hak Chul¹⁵,Choi Sung Hee¹⁵

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

2. Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.

3. Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.

4. Department of Internal Medicine, Konkuk University Chungju Hospital, Konkuk University School of Medicine, Chungju, Korea.

5. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Publisher

Korean Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.4093/dmj.2015.39.6.489

Reference24 articles.

1. Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice

2. β-Cell Failure in Diabetes and Preservation by Clinical Treatment

3. Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)

4. Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population

5. Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetes

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes;Medicine;2016-11